Sheila DeWitt
Vermögen: 17 912 $ am 31.05.2026
Vermögen: 17 912 $ am 31.05.2026
Sheila DeWitt is the founder of Deuterx LLC, founded in 2012, holding the titles of Chairman, President & Chief Executive Officer.
Dr. DeWitt is also the founder of Diversomer Technologies, Inc...
Dr. DeWitt currently serves as Director at Riffit, Inc., Chief Operating Officer & Director at Neuromity Therapeutics, Inc., and Independent Director at Enveric Biosciences, Inc. since 2024.
Former positions include Chairman, President & Chief Executive Officer at Deuteria Pharmaceuticals, Inc. from 2010 to 2012, Vice President-Portfolio Development at ArQule, Inc., Vice President-Discovery at EPIX Pharmaceuticals, Inc. from 2005 to 2009, and Business Unit Head at Orchid Cellmark, Inc. Education includes a doctorate from Duke University conferred in 1986 and an undergraduate degree from Cornell University conferred in 1982.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 7.788 ( 0,21 % ) | 17 912 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 01.05.2024 |
Deuterx LLC
Deuterx LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company provides drugs for patients | Vorstandsvorsitzender | 01.01.2012 |
Riffit, Inc.
Riffit, Inc. Medical/Nursing ServicesHealth Services Provides musical therapy solutions | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Deuteria Pharmaceuticals, Inc.
Deuteria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | 01.12.2012 |
Diversomer Technologies, Inc. | Gründer | - |
| ARQULE, INC. | Corporate Officer/Principal | - |
Orchid Cellmark, Inc.
Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Corporate Officer/Principal | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
Orchid Cellmark, Inc.
Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Commercial Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Diversomer Technologies, Inc. | |
Deuterx LLC
Deuterx LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company provides drugs for patients | Health Technology |
Deuteria Pharmaceuticals, Inc.
Deuteria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Enveric Biosciences, Inc.
Enveric Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Health Technology |
Riffit, Inc.
Riffit, Inc. Medical/Nursing ServicesHealth Services Provides musical therapy solutions | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen